Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

Clinical trial NCT06375473 · RECRUITING

Trial details

NCT number: NCT06375473
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Pancreatic Cancer

Start date: 2024-04-19
Primary completion: 2027-04-19
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.